In contrast to SMM, the dynamics of the CMMCs under treatment in the MM patients accurately mirrored that of the biochemical indicators, demonstrating highly significant relationships with M-protein, kappa/lambda ratio, and β2M (p < 0.0001). This evidence concerns the gene MYOM2 and Miyoshi myopathy.